Mar 19 |
Adicet Bio: Q4 Earnings Insights
|
Mar 19 |
Adicet Bio GAAP EPS of -$0.69 beats by $0.01
|
Mar 19 |
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
|
Mar 11 |
Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
|
Feb 13 |
Jones upgrades Adicet to buy, cites upcoming catalysts
|
Feb 5 |
Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
|
Jan 25 |
Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
|
Jan 23 |
Adicet Bio announces pricing of public offering
|
Jan 23 |
Adicet Bio, Inc. Announces Pricing of Public Offering
|
Jan 22 |
Adicet Bio stock sinks on proposed public offering
|